Abstract:BackgroundMycoplasma pneumoniae (M. pneumoniae) is a commonly causative pathogen for respiratory tract infections (RTIs) in humans. The epidemiological features of M. pneumoniae infections during post-epidemic, including age distribution and the seasonality of the patients, are not well investigated.MethodsWe retrospectively analyzed the clinical data of 7835 consecutive RTIs patients (3852 adults and 3983 children) who visited a teaching hospital, and defined an epidemic (2011–2013) and a post-epidemic period (2014–2016). M. pneumoniae was detected by fluorescence-quantatitive PCR in respiratory samples. Informed consent was obtained by all adults and the legal representatives of patients aged < 18 years, and the study was approved by Institutional Review Board of Beijing Chao-Yang Hospital (project approval number 10-KE-49).ResultsThe median (IQR) age was 16 (53) years (range < 0–105 years). The M. pneumoniae positive rate was 14.4% (21.2%, epidemic; 6.7%, post-epidemic), with seasonal peaks from late summer to autumn during epidemic, and from fall to winter during post-epidemic period, which was highest in children aged 7–17 years. In epidemic, no statistical difference was found in the positive rates between children and adults among most months (except February, July and August), neither for the positive rates among age groups (P = 0.801). However, in post-epidemic period, significant differences were observed in the positive rates between children and adults in nearly every month (P< 0.05 or P< 0.001, except May), as well as in the positive rates among age groups (P< 0.001). Most of the older patient admissions and all of ICU admissions occurred during the epidemic.ConclusionsDifferent patterns of age distribution and seasonality of M. pneumoniae RTIs between epidemic and post-epidemic periods were reported. Our results suggest that M. pneumoniae should be considered as a possible pathogen in pneumonia patients admitted to the ICU in the setting of an epidemic.

Current Status of Mycoplasma Pneumoniae Infection in China

The Clinical And Molecular Epidemiology Of Mycoplasma Pneumoniae Infections

Surveillance of Mycoplasma Pneumoniae Infection among Children in Beijing from 2007 to 2012

Mycoplasma Pneumoniae Infection in Hospitalized Adult Patients with Community-Acquired Pneumonia in China.

Progress in the Diagnosis and Treatment of Childhood Mycoplasma Pneumoniae Infections

Mycoplasma Pneumoniae‐associated Necrotizing Pneumonitis in Children

Epidemiological Characteristics and Meteorological Factors of Childhood Mycoplasma Pneumoniae Pneumonia in Hangzhou

Emerging trends and concerns in Mycoplasma pneumoniae pneumonia among Chinese pediatric population

New progress in etiological diagnosis and treatment of mycoplasma pneumoniae infection

Study of Two Separate Types of Macrolide-Resistant Mycoplasma Pneumoniae Outbreaks

Mycoplasma Pneumoniae and Bronchial Asthma

The epidemic characteristics of Mycoplasma pneumoniae infection among children in Anhui, China, 2015–2023

Epidemiology of Mycoplasma pneumoniae in children with acute respiratory infections in Hangzhou during January 2021 to June 2023

Impact of COVID-19 on the Epidemiological Features of Mycoplasma pneumoniae Infection in Children with Community-Acquired Pneumonia in Henan, China

Therapeutic progress of Mycoplasma pneumoniae pneumonia in children

Epidemiological Characteristics of Mycoplasma pneumoniae in Hospitalized Children with Pneumonia in Hangzhou, China

Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic

Contemporary situation of community-acquired pneumonia in China: A systematic review

Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multi-center study.

Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study

Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016